Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Delafloxacin
  • 1.4.3 Vancomycin
  • 1.4.4 Ceftaroline Fosamil
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2025)
  • 1.5.2 Cellulitis
  • 1.5.3 Abscess
  • 1.5.4 Surgical Wounds
  • 1.5.5 Traumatic Wound
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size
• 2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Trends by Regions
  • 2.2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions (2019-2025)
  • 2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by by Players
  • 3.1.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by by Players (2014-2019)
  • 3.1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio (CR5 and HHI)
• 3.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players Head office and Area Served
• 3.3 Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product/Solution/Service
• 3.4 Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2014-2019)
• 4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2014-2019)

5 North America

• 5.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2014-2019)
• 5.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in North America
• 5.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
• 5.4 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

6 Europe

• 6.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2014-2019)
• 6.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Europe
• 6.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
• 6.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

7 China

• 7.1 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2014-2019)
• 7.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in China
• 7.3 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
• 7.4 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

8 Japan

• 8.1 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2014-2019)
• 8.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Japan
• 8.3 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
• 8.4 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2014-2019)
• 9.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Southeast Asia
• 9.3 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
• 9.4 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

10 India

• 10.1 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2014-2019)
• 10.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in India
• 10.3 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
• 10.4 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

11 Central & South America

• 11.1 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2014-2019)
• 11.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Central & South America
• 11.3 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
• 11.4 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

12 International Players Profiles

• 12.1 Furiex Pharmaceuticals, Inc.
  • 12.1.1 Furiex Pharmaceuticals, Inc. Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.1.4 Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019))
  • 12.1.5 Furiex Pharmaceuticals, Inc. Recent Development
• 12.2 GlaxoSmithKline plc
  • 12.2.1 GlaxoSmithKline plc Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.2.4 GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.2.5 GlaxoSmithKline plc Recent Development
• 12.3 Melinta Therapeutics, Inc.
  • 12.3.1 Melinta Therapeutics, Inc. Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.3.4 Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.3.5 Melinta Therapeutics, Inc. Recent Development
• 12.4 Debiopharm International S.A.
  • 12.4.1 Debiopharm International S.A. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.4.4 Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.4.5 Debiopharm International S.A. Recent Development
• 12.5 MerLion Pharmaceuticals Pte Ltd.
  • 12.5.1 MerLion Pharmaceuticals Pte Ltd. Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.5.4 MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.5.5 MerLion Pharmaceuticals Pte Ltd. Recent Development
• 12.6 Durata Therapeutics, Inc.
  • 12.6.1 Durata Therapeutics, Inc. Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.6.4 Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.6.5 Durata Therapeutics, Inc. Recent Development
• 12.7 Paratek Pharmaceuticals, Inc.
  • 12.7.1 Paratek Pharmaceuticals, Inc. Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.7.4 Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.7.5 Paratek Pharmaceuticals, Inc. Recent Development
• 12.8 Cempra, Inc.
  • 12.8.1 Cempra, Inc. Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.8.4 Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.8.5 Cempra, Inc. Recent Development
• 12.9 Abbott Laboratories, Inc.
  • 12.9.1 Abbott Laboratories, Inc. Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.9.4 Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.9.5 Abbott Laboratories, Inc. Recent Development
• 12.10 Actelion Pharmaceuticals Ltd.
  • 12.10.1 Actelion Pharmaceuticals Ltd. Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
  • 12.10.4 Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2014-2019)
  • 12.10.5 Actelion Pharmaceuticals Ltd. Recent Development
• 12.11 Albany Molecular Research, Inc.
• 12.12 Allergan plc.
• 12.13 AstraZeneca
• 12.14 Bayer AG
• 12.15 Macrolide Pharmaceuticals, Inc.
• 12.16 Merck & Co, Inc.
• 12.17 Pfizer, Inc.
• 12.18 Sanofi
• 12.19 Teva Pharmaceuticals Industries Ltd.
• 12.20 Zavante Therapeutics, Inc.

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer